La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Dopamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopa Decarboxylase < Dopamine < Dopamine Agents  Facettes :

List of bibliographic references indexed by Dopamine

Number of relevant bibliographic references: 262.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000243 (2016) Edith Miville-Godbout [Canada] ; Mélanie Bourque [Canada] ; Marc Morissette [Canada] ; Sara Al-Sweidi [Canada] ; Tara Smith [Canada] ; Asuka Mochizuki [Canada, Japon] ; Vijitha Senanayake [Canada] ; Dushmanthi Jayasinghe [Canada] ; Li Wang [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada]Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
000262 (2016) Julieta E. Arena [Canada] ; A Jon Stoessl [Canada]Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
000273 (2016) Mohammed Filali [Canada] ; Robert Lalonde [France]Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.
000314 (2016) F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada]Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
000429 (2016) Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip SeemanBinding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000449 (2016) Michael D. Staudt [Canada] ; Andrea R. Di Sebastiano ; Hu Xu ; Mandar Jog ; Susanne Schmid ; Paula Foster ; Matthew O. HebbAdvances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
000454 (2016) Dimitri Ryczko [Canada] ; Jackson J. Cone ; Michael H. Alpert ; Laurent Goetz [Canada] ; François Auclair [Canada] ; Catherine Dubé [Canada] ; Martin Parent [Canada] ; Mitchell F. Roitman ; Simon Alford ; Réjean Dubuc [Canada]A descending dopamine pathway conserved from basal vertebrates to mammals
000470 (2015) Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000505 (2015) Matt J N. Brown [Canada] ; Quincy J. Almeida ; Fariborz RahimiThe dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD).
000570 (2015) Y. Wang [Canada] ; Z. Zhou [Canada] ; T. Leylek [Canada] ; H. Tan [Canada] ; Y. Sun [Canada] ; F E Parkinson [Canada] ; J-F Wang [Canada]Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters.
000573 (2015) M. Yue [États-Unis] ; K. Hinkle [États-Unis] ; P. Davies [Royaume-Uni] ; E. Trushina [États-Unis] ; F. Fiesel [États-Unis] ; T. Christenson [États-Unis] ; A. Schroeder [États-Unis] ; L. Zhang [États-Unis] ; E. Bowles [États-Unis] ; B. Behrouz [États-Unis] ; S. Lincoln [États-Unis] ; J. Beevers [États-Unis] ; A. Milnerwood [Canada] ; A. Kurti [États-Unis] ; P. J. Mclean [États-Unis] ; J. D. Fryer [États-Unis] ; W. Springer [États-Unis] ; D. Dickson [États-Unis] ; M. Farrer [Canada] ; H. Melrose [États-Unis]Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock in mice
000610 (2015) Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud]Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
000642 (2015) I. Aracil-Bola Os [Canada] ; A. P. Strafella [Canada]Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease
000648 (2015) Yueting Shao [Canada] ; Daniel Figeys ; Zhibin Ning ; Ryan Mailloux ; Hing Man ChanMethylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
000665 (2015) Dayne A. Beccano-Kelly ; Mattia Volta ; Lise N. Munsie ; Sarah A. Paschall ; Igor Tatarnikov ; Kimberley Co ; Patrick Chou ; Li-Ping Cao ; Sabrina Bergeron ; Emma Mitchell ; Heather Han ; Heather L. Melrose [États-Unis] ; Lucia Tapia ; Lynn A. Raymond [Canada] ; Matthew J. Farrer ; Austen J. Milnerwood [Canada]LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.
000709 (2015) Emily M. Rocha [États-Unis] ; Gaynor A. Smith [États-Unis] ; Eric Park [États-Unis] ; Hongmei Cao [États-Unis] ; Eilish Brown [États-Unis] ; Melissa A. Hayes [États-Unis] ; Jonathan Beagan [États-Unis] ; Jesse R. Mclean [États-Unis] ; Sarah C. Izen [États-Unis] ; Eduardo Perez-Torres [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis]Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
000712 (2015) Arash Nazeri [Canada] ; Tina Roostaei [Canada] ; Shokufeh Sadaghiani [Canada] ; M Mallar Chakravarty [Canada] ; Shirley Eberly [États-Unis] ; Anthony E. Lang [Canada] ; Aristotle N. Voineskos [Canada]Genome-wide variant by serum urate interaction in Parkinson's disease.
000798 (2015) Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Igor Tatarnikov [Canada] ; Patrick Chou [Canada] ; Sabrina Bergeron [Canada] ; Emma Mitchell [Canada] ; Roscoe Lim [Canada] ; Jaskaran Khinda [Canada] ; Alejandro Lloret [États-Unis] ; C Frank Bennett [États-Unis] ; Carmela Paradiso [Italie] ; Michele Morari [Italie] ; Matthew J. Farrer [Canada] ; Austen J. Milnerwood [Canada]Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.
000827 (2015) María Sierra [Espagne] ; Sébastien Carnicella [France] ; Antonio P. Strafella [Canada] ; Amélie Bichon [France] ; Eugénie Lhommée [France] ; Anna Castrioto [France] ; Stephan Chabardes [France] ; Stéphane Thobois [France] ; Paul Krack [France]Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.
000849 (2015) Daryl J. Wile [Canada] ; Katie Dinelle [Canada] ; Nasim Vafai [Canada] ; Jessamyn Mckenzie [Canada] ; Joseph K. Tsui [Canada] ; Paul Schaffer [Canada] ; Yu-Shin Ding [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada]A Scan Without Evidence Is Not Evidence of Absence: Scans Without Evidence of Dopaminergic Deficit in a Symptomatic Leucine-Rich repeat Kinase 2 Mutation Carrier
000851 (2015) Beryl Luk [Canada] ; Mohinuddin Mohammed [Canada] ; Fang Liu [Canada] ; Frank J. S. Lee [Canada]A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Dopamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022